ROCHE Finance Ltd., 10% Owner at Jasper Therapeutics, Inc. (JSPR), sold 75,000 shares at $1.89 ($142K) on 2023-01-25, disclosed to the SEC on 2023-01-26.
Open-market sale of $142k JSPR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.